Metaimmunetech develops digital inline holography technology for single-cell analysis to evaluate immune cell activity in patients with rare metabolic diseases and cancer. This approach enables the creation of natural product-based medicines and health functional foods that enhance patient recovery and disease prevention.
Funding
Funding not disclosed
Founders
Product
Problem
Evaluating immune cell activity in patients with rare metabolic diseases and cancer often relies on traditional methods that can be time-consuming, costly, and lack the precision needed for personalized medicine. Conventional single-cell analysis techniques may not provide a comprehensive understanding of immune cell function in response to various stimuli. This can hinder the development of effective natural product-based medicines and health functional foods.
Solution
Metaimmunetech offers a digital inline holography platform, Cellytics, for rapid and precise single-cell analysis, enabling a deeper understanding of immune cell activity. This label-free technology allows for real-time monitoring of individual immune cells, providing quantitative data on cell morphology, motility, and interactions. The Cellytics platform facilitates high-throughput screening of natural compounds and drug candidates, accelerating the discovery and development of immunomodulatory therapeutics and health functional foods. By providing detailed insights into immune cell behavior, Metaimmunetech supports the creation of personalized treatment strategies for patients with rare metabolic diseases and cancer.
Target Audience
The primary customers are researchers and pharmaceutical companies involved in drug discovery, particularly those focused on immunology, metabolic diseases, and oncology, as well as healthcare providers seeking advanced diagnostic tools for personalized medicine.
Features
- Digital inline holography for non-invasive, real-time single-cell analysis
- Label-free imaging eliminates the need for fluorescent dyes or antibodies
- High-throughput screening capabilities for rapid identification of active compounds
- Quantitative data on cell morphology, motility, and cell-cell interactions
- AI-powered image analysis for automated cell segmentation and tracking
- Integrated software for data visualization and reporting
- Customizable assays for evaluating immune cell function in response to various stimuli